HHL:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 8.76

Change

+0.04 (+0.46)%

Market Cap

N/A

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.14 (+0.35%)

CAD 2.88B
TEC:CA TD Global Technology Leaders I..

+0.14 (+0.35%)

CAD 2.88B
ZWU:CA BMO Covered Call Utilities ETF

N/A

CAD 1.94B
ZWU:CA BMO Covered Call Utilities ETF

N/A

CAD 1.94B
XHC:CA iShares Global Healthcare (CAD..

+0.21 (+0.28%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

+0.21 (+0.28%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

+0.49 (+0.85%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

+0.49 (+0.85%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

N/A

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

N/A

CAD 0.65B

ETFs Containing HHL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.09% 39% F 43% F
Dividend Return 6.60% 98% N/A 96% N/A
Total Return 15.69% 71% C- 58% F
Trailing 12 Months  
Capital Gain 13.47% 24% F 40% F
Dividend Return 9.13% 91% A- 97% N/A
Total Return 22.60% 46% F 54% F
Trailing 5 Years  
Capital Gain 22.18% 30% F 51% F
Dividend Return 36.66% 98% N/A 96% N/A
Total Return 58.84% 46% F 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 2.14% N/A N/A 46% F
Dividend Return 8.83% N/A N/A 62% D
Total Return 6.69% N/A N/A 98% N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.86% N/A N/A 55% F
Risk Adjusted Return 99.63% N/A N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike